RENVELA 0.8 g, powder for oral suspension 90 sachets
Active ingredients: Sevelamer carbonate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspension90 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RENVELA 0,8 g, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 90 sachet(s) copolymère d'éthylène et d'acide méthacrylique polytéréphtalate (PET) polyéthylène basse densité (PEBD) aluminium avec cuillère doseuse
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63716917CIP73019964CIP133400930199640Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉVÉLAMER (CARBONATE DE)poudre | 0,8 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.